pharma Β· Inflammatory Bowel Disease (IBD) Β· Melanoma Β· IRON
Disc Medicine
Disc Medicine clinical programs β 59 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
- Employees
- 165
- Programs
- 308
- Drugs
- 442
- Patents
- 706
Disc Medicine projects
59 ClinicalTrials.gov programs sponsored by Disc Medicine.
Disc Medicine has 59 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
-
Disc Medicine
Resectable colorectal rectal metastases without extrahepatic disease
1 trial -
115747
Disc Medicine
Metastatic renal cell carcinoma
1 trial -
116130
Disc Medicine
Parkinson's disease
1 trial -
14395
Disc Medicine
ABC borderline resectable pancreatic cancer
1 trial -
18-791
Disc Medicine
Brain injury in neonates with critical congenital heart disease requiring cardiac surgery with cardiopulmonary bypass.
1 trial -
202100617
Disc Medicine
Combined endpoint of all-cause mortality, kidney failure, and hospitalization for heart failure in the overall study population
1 trial -
22817
Disc Medicine
chronic kidney disease
1 trial -
89Zr-CED88004S
Disc Medicine
Large B-cell lymphoma
1 trial -
AchilleS tendinoPathy treated with cortIcosteRoid injEctions.
Disc Medicine
Achilles tendinopathy
1 trial -
Bitopertin
Disc Medicine
X-Linked Protoporphyria (XLP), Erythropoietic Protoporphyria (EPP)
1 trial -
Bitopertin, Matching Placebo
Disc Medicine
X-Linked Protoporphyria (XLP), Erythropoietic Protoporphyria (EPP)
1 trial -
CAPECITABINE
Disc Medicine
Salivary Duct Carcinoma
1 trial -
CETUXIMAB
Disc Medicine
oral squamous cell carcinoma
1 trial -
Concurrent chemotherapy
Disc Medicine
Uterine Cervical Neoplasms
1 trial -
DAPAGLIFLOZIN, PLACEBO
Disc Medicine
Hypomagnesemia due to HNF1beta mutation
1 trial -
DIDaC/ NVALT35
Disc Medicine
Patients with advanced, metastatic NSCLC that have not progressed on a standard of care immunotherapy regimen 6 months after initiation of first line treatment.
1 trial -
DISC-1459
Disc Medicine
Erythropoietic Protoporphyria
2 trials -
ETIDRONATE DISODIUM ORAL CAPSULES 400 MG
Disc Medicine
Pseudoxanthoma Elasticum
1 trial -
FET
Disc Medicine
ACTH-dependent hypercortisolism
1 trial -
FLUOROURACIL for Rectal cancer
Disc Medicine
Rectal cancer
1 trial -
GALLIUM (68GA) CHLORIDE, TILMANOCEPT
Disc Medicine
Carcinoma of the parotid gland
1 trial -
GALLIUM (68GA) CHLORIDE, TILMANOCEPT
Disc Medicine
Endometrial cancer, uterine cancer
1 trial -
Glucose 5% 50 ml
Disc Medicine
Apnea of prematurity
1 trial -
HEPARIN , NADROPARIN
Disc Medicine
All patients who receive ECMO treatment during the study period in one the participating centers from which (deferred) informed consent is obtained. Patients in whom the ECMO is only used to bridge a procedure like a high risk percutaneous coronary intervention or during surgery are excluded.
1 trial -
INTENSIFY BD
Disc Medicine
Bipolar depression
1 trial -
INTENSIFY MDD
Disc Medicine
Major depressive disorder
1 trial -
Instant MSC Product accompanying Autologous Chondron Transplantation (IMPACT)
Disc Medicine
Symptomatic articular cartilage lesion of the knee (femoral condyles or trochlea)
1 trial -
Insulatard 100 international units/ml suspens... for Delirium
Disc Medicine
Delirium
1 trial -
Irinotecan HCl-trihydraat Accord /ml concentr...
Disc Medicine
Non-metastatic resectable pancreatic cancer
1 trial -
Irinotecan HCl-trihydraat Fresenius Kabi /ml
Disc Medicine
non-metastatic (borderline) resectable pancreatic cancer
1 trial -
KEYTRUDA 25 mg/mL concentrate for solution for infusion
Disc Medicine
Advanced NSCLC
1 trial -
Ketanest-S 25 Multi-dose for Non-psychotic therapy resistantβ¦
Disc Medicine
Non-psychotic therapy resistant unipolar depression
1 trial -
Kyprolis powder for relapsed/refractory multiple myβ¦
Disc Medicine
relapsed/refractory multiple myeloma
1 trial -
LEUPRORELIN
Disc Medicine
polycystic liver disease
1 trial -
LIOTHYRONINE for Hypothyroidism Triiodothyronineβ¦
Disc Medicine
Hypothyroidism Triiodothyronine Quality of Life Persistant complaints
1 trial -
Lactose monohydrate for Chronic low back pain
Disc Medicine
Chronic low back pain
1 trial -
Leflunomide Mylan for polymyalgia rheumatica
Disc Medicine
polymyalgia rheumatica
1 trial -
METFORMIN for PASC: post-acute sequelae of SARS-CoV-2 infection
Disc Medicine
PASC: post-acute sequelae of SARS-CoV-2 infection
1 trial -
METFORMIN, COLCHICINE
Disc Medicine
PASC: post-acute sequelae of SARS-CoV-2 infection
1 trial -
Modiodal 100 mg tabletten, PLACEBO
Disc Medicine
Inflammatory bowel disease, Fatigue
1 trial -
NCT02735707
Disc Medicine
Respiratory tract infection
1 trial -
NL79088.041.21
Disc Medicine
Primary antibody deficiency: - Unclassified antibody deficiency (unPAD) - IgA deficiency - Specific polysaccharide antibody deficiency (SPAD) - IgG subclass deficiency (IgSD) - Common variable immunodeficiency (CVID) - Agammaglobulinemia (X-linked or otherwise)
1 trial -
NL79665.058.22
Disc Medicine
Cluster headache
1 trial -
OPDIVO 10 mg/mL concentrate for solution for infusion.
Disc Medicine
oesophageal cancer
1 trial -
PLASMA for Coagulation in pediatric cardiaβ¦
Disc Medicine
Coagulation in pediatric cardiac surgery
1 trial -
PROGRAF for lung transplantation
Disc Medicine
lung transplantation
1 trial -
Placebo
Disc Medicine
Erythropoietic Protoporphyria (EPP)
1 trial -
Placebo Colchicine tablets for Aortic Valve Calcification, Infβ¦
Disc Medicine
Aortic Valve Calcification, Inflammation, Calcification, Aortic Valve Disease, Cardiovascular Diseases, Aortic Valve Stenosis
1 trial
Frequently asked questions
How many clinical projects does Disc Medicine have?
59 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.